
'Maximising Returns from Life Science Innovation'
Whether addressing global health challenges, sustainability, economics, or inclusion & equality, there has perhaps never been such collective drive and desire to ensure all stakeholders can participate in, and derive benefit from, scientific and business innovation.
The 2023 Keynote Programme at Genesis will explore how innovation in Life Sciences is leading to inclusive stakeholder rewards.
Thursday 7 December 2023 - Keynote Programme
08.30 | Registration |
09.00 | Welcome from One Nucleus |
Jon Green, One Nucleus | |
![]() |
|
09.10 | Keynote Address: Winners & Losers 2023 |
Mike Ward, Clarivate | |
![]() |
|
09.30 | Panel: Bio-Finance Briefing |
What do the investment and dealmaking trends observed through the past year tell us about what to expect in the year ahead? | |
10.30 | Coffee Break |
11.00 | Panel: Buy, Borrow or Grow-Your-Own? |
As the R&D pipeline and business develops in an increasingly multi-disciplinary sector new competences are required to progress. What drives the board’s strategic decisions for growth? | |
11.40 | Why We Should Win This Award! |
5-minute presentations from the six finalists of the 2023 Genesis BioNewsRound |
|
12.30 | Lunch |
13.40 | So, What Do You Think? |
Two leaders from the sector chatting one-to-one about a key question in the sector. A chance for each delegate to be a fly on the wall of a conversation they would like to see play out. |
|
14.00 | Replicating the Real World When Developing New Medicines and Technologies to Improve Outcomes |
A model is just a model when it comes to testing a hypothesis. As technology enables greater use of real-world evidence at the in vitro, in vivo or clinical stages, how can we increase the predictability in translational research? | |
14.40 | This House Believes...tbc |
A chance for two presenters to present the pros vs the cons of an industry question followed by an audience vote |
|
15.00 | Coffee Break |
15.30 | Panel: Making Better Patient Outcomes Affordable |
Healthcare systems are finding increasing costs to care for their citizens rising at a rate perceived to be unsustainable rate. Whether through increased productivity, cost reductions, new payment models or other, how can innovation be afforded? |
|
16.10 | Panel: The Anatomy of a Great Dealmaker |
The Life Sciences sector, and one may argue life in general, is full of strategy, compromise, negotiation. What are the key personal attributes required to be a great dealmaker? |
|
16.50 | Closing Remarks |
17.00 | Drinks Reception |
18.00 | Close |